Aristotelis Bamias - Hygeia Hospital;Medical School, University of Athens

基本信息

Career Trajectory

Bio

Honors & Awards
Included among the most cited Greek scientists (Edition Kedros: «Tracta-tus για την έκτη φήμη» by John Ioannides, Professor of Biostatistics, Stan-ford University, pages 62-75, list available upon request)
Member of the Faculty of the Educational Committee of the European School of Medical Oncology (ESMO)-Genitourinary Group (2012-cont’d). Co-ordinator of the Group 2016-2020.
Member of the international Panel of Experts for the Guidelines for the management of prostate cancer (2007)

Research Interests

Papers共 606 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Review of BCG Immunotherapy for Bladder Cancer

George D Liatsos, Ilias Mariolis,Emilia Hadziyannis,Aristotelis Bamias, Dimitrios Vassilopoulos

Clinical microbiology reviewspp.e0019423-e0019423, (2025)

Cited0Views0WOSBibtex

Towards a Consensus on the Management of Metastatic Renal Cell Carcinoma: Insights from a European Delphi Study

Laurence Albiges, Marine Gross-Goupil, Philippe Barthélémy,Aristotelis Bamias, Jens Bedke,Axel Bex, Mário Fontes-Sousa,Viktor Grünwald,Bohuslav Melichar, Lisa Pickering,Camillo Porta,Giuseppe Procopio, Sylvie Rottey, Manuela Schmidinger,Cristina Suárez,Guillermo Velasco,Bernard Escudier

European Urology Oncology (2025)

Cited0Views0WOSBibtex

Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer

Matthew D Galsky,Mark Kockx, Juliette Roels, Roos Van Elzen, Xiangnan Guan,Kobe Yuen,Deepali Rishipathak, Jonathan F Anker,Sacha Gnjatic,Sudeh Izadmehr, Shomyesh Sanjabi, Robert J Johnston, Maureen Peterson,Hartmut Koeppen, Justin M David, Saurabh Gupta,Aristotelis Bamias,Jose Angel Arranz, Eiji Kikuchi,Maria De Santis,Ian D Davis,Patrick Williams,Sandrine Bernhard,Ira Mellman,Enrique Grande,Romain Banchereau,Sanjeev Mariathasan

Cancer immunology research (2025)

Cited0Views0WOSBibtex

Clinical Outcomes with Immune Checkpoint Inhibitors in Patients with FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma

Rafee Talukder, Dimitra Rafailia Bakaloudi,Dimitrios Makrakis,Leonidas N. Diamantopoulos, Thomas Enright, Jacob B. Leary,Ruben Raychaudhuri,Nishita Tripathi,Neeraj Agarwal,Tanya Jindal,Jason R. Brown,Yousef Zakharia, Macarena Rey-Cardenas,Daniel Castellano,Charles B. Nguyen,Ajjai Alva,Roubini Zakopoulou,Aristotelis Bamias,Rafael Morales Barrera, David Marmolejo, Alexandra Drakaki, David J. Pinato, James Korolewicz, Lucia Alonso Buznego, Ignacio Duran, Clara Castro Carballeira, Rana R. Mckay, Tyler F. Stewart, Shilpa Gupta, Pedro Barata, Evan Y. Yu, Vadim S. Koshkin, Ali Raza Khaki, Petros Grivas

CLINICAL GENITOURINARY CANCERno. 1 (2025)

Cited0Views0WOSBibtex

Up-regulation of Cuproptosis-related Lncrnas in Patients Receiving Immunotherapy for Metastatic Clear Cell Renal Cell Carcinoma Indicates Progressive Disease

Hector Katifelis,Stamatiki Grammatikaki,Roubini Zakopoulou,Aristotelis Bamias, Michalis Karamouzis,Konstantinos Stravodimos,Maria Gazouli

IN VIVOno. 1 (2025): 146-151

Cited0Views0WOSBibtex

Treatment of Advanced Urothelial Cancer with Nivolumab Plus Chemotherapy Versus Chemotherapy Alone (checkmate 901 Study): a Plain Language Summary

Michiel S van der Heijden,Guru Sonpavde,Thomas Powles,Andrea Necchi,Mauricio Burotto,Michael Schenker,Juan Pablo Sade,Aristotelis Bamias,Philippe Beuzeboc, Jens Bedke,Jan Oldenburg, Gurkamal Chatta,Yüksel Ürün,Dingwei Ye,Zhisong He,Begoña P Valderrama,Ja Hyeon Ku, Yoshihiko Tomita, Jeiry Filian, Lily Wang, Daniela Purcea, Miraj Y Patel,Federico Nasroulah, Matthew D Galsky

Future oncology (London, England)pp.1-12, (2025)

Cited0Views0WOSBibtex

Intravesical Administration of Durvalumab for High-risk Non–muscle-invasive Bladder Cancer: A Phase 2 Study by the Hellenic GU Cancer Group

Charalampos Fragkoulis,Aristotelis Bamias, Nikos Gavalas,Kimon Tzannis, Evangelos Fragiadis,Alexandros Pinitas, Panayiotis V. Stamatakos, George Papadopoulos, George Stathouros, Xanthippi Grammatoglou,Penelope Korkolopoulou, Christina Zoubouli,Konstantinos Stravodimos,Konstantinos Ntoumas,Dionysios Mitropoulos,Andreas Skolarikos,Athanasios Papatsoris

European Urology (2025)

Cited0Views0WOSBibtex

1716P Primary Resistance to Front-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1)

M. Catalano,G. Roviello, S. Buti, F. Massari, H. Li, S.H. Park,E. Grande, J. Kucharz, O. Fiala,A. Poprach,T. Buchler,E. Seront,J. Ansari, Z.W. Myint, D.M. Bhuva,A. Bamias, M. Ghosn, S. Andrey,M. Santoni,D. Santini

Annals of Oncology (2024): S1028-S1029

Cited0Views0Bibtex

Nivolumab (NIVO) Plus Gemcitabine-Cisplatin (GC) Vs GC Alone for Previously Untreated Unresectable or Metastatic Urothelial Carcinoma (muc): Results from the Phase 3 CheckMate 901 Trial

Jens Bedke,Michiel S. van der Heijden,Guru Sonpavde,Thomas Powles,Andrea Necchi, Mauricio Burotto,Michael Schenker,Juan Pablo Sade,Aristotelis Bamias, Philippe Beuzeboc,Jan Oldenburg,Yuksel Urun,Dingwei Ye,Zhisong He,Begona P. Valderrama,Yoshihiko Tomita, Jeiry Filian, Daniela Purcea,Federico Nasroulah,Matthew Galsky

ONCOLOGY RESEARCH AND TREATMENT (2024): 230-230

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn